Search Results

Filter
  • 1-2 of  2 results for ""Han, Jenny""
Item request has been placed! ×
Item request cannot be made. ×
  Processing Request
Academic Journal

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.

  • Authors : Meloni AR; Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive, San Diego, CA, 92121, USA.; DeYoung MB

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Cardiovascular Diabetology [Cardiovasc Diabetol] 2013 Mar 23; Vol. 12, pp. 48. Date of Electronic Publication: 2013 Mar 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
Academic Journal

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.

  • Authors : Ratner R; MedStar Health Research Institute, Hyattsville, MD, USA.; Han J

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Cardiovascular Diabetology [Cardiovasc Diabetol] 2011 Mar 16; Vol. 10, pp. 22. Date of Electronic Publication: 2011 Mar 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
  • 1-2 of  2 results for ""Han, Jenny""